Insight

Gabriel Aleixo: Initiating cancer treatment at a lower dose and gradually escalating it

Gabriel Aleixo/X

Nov 15, 2024, 07:57

Gabriel Aleixo: Initiating cancer treatment at a lower dose and gradually escalating it

Gabriel Aleixo, Clinical Fellow in Hematology-Oncology at the University of Pennsylvania, shared a post on X about a recent paper by him and colleagues, published in Journal of Geriatric Oncology.

“Start low, go slow,” a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis”

Authors: Gabriel Aleixo, Tej Patel, Julianne Ani, Will Ferrell, Efrat Dotan, Samuel Takvorian, Grant Williams, Ravi Parikh, Ramy Sedhom.

“Our article on initiating cancer treatment at a lower dose and gradually escalating the dose if the patient tolerates it well.”

Grant Williams, Medical Oncologist and Geriatrician at the University of Alabama at Birmingham, shared this post, adding:

“Great job on this, a critically important strategy that warrants more investigation.”

For more posts like this, visit oncodaily.com.

Gabriel Aleixo is a Clinical Fellow in Hematology-Oncology at the University of Pennsylvania, specializing in Geriatric Oncology. His work focuses on developing patient-centered therapies for older adults with cancer.

Alongside his fellowship, he is pursuing a Master’s in Clinical Epidemiology. His research integrates digital health tools, biomarkers, and pragmatic clinical trials to bridge the gap between oncology and geriatric care.

Grant R. Williams is a Medical Oncologist and Geriatrician at the University of Alabama at Birmingham, focusing on the management of gastrointestinal malignancies. His research and clinical care emphasize the intersection of cancer and aging, aiming to provide personalized, evidence-based care for frail and vulnerable older adults with cancer.

Dr. Williams is an Associate Professor in Hematology and Oncology and holds several roles as an Associate Scientist across various research centers at the University of Alabama at Birmingham.